A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma

PURPOSE: Neutropenia is a common complication from chemotherapy, limiting optimal dosing and treatment. Lipegfilgrastim is a long-acting granulocyte colony-stimulating factor developed for the management of chemotherapy-induced neutropenia. The objectives of this phase 1, multinational, open-label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Belogurova, Margarita B., Kizyma, Zoryana P., Garami, Miklós, Csóka, Mónika, Lamson, Michael J., Buchner, Anton, Bias, Peter, Lammerich, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225185/
https://www.ncbi.nlm.nih.gov/pubmed/27986986
http://dx.doi.org/10.1007/s00280-016-3216-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225185/
https://www.ncbi.nlm.nih.gov/pubmed/27986986
http://dx.doi.org/10.1007/s00280-016-3216-2

Ejemplares similares